|
gptkbp:instanceOf
|
chemical compound family
|
|
gptkbp:actsOn
|
5-HT2A receptor
|
|
gptkbp:alsoKnownAs
|
25X-NBOMe
|
|
gptkbp:bannedIn
|
gptkb:Australia
gptkb:Canada
gptkb:China
gptkb:Germany
gptkb:Russia
gptkb:Sweden
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:chemicalClass
|
amphetamine
psychedelic
|
|
gptkbp:contains
|
gptkb:25B-NBOMe
gptkb:25C-NBOMe
gptkb:25D-NBOMe
gptkb:25E-NBOMe
gptkb:25H-NBOMe
gptkb:25I-NBOMe
gptkb:25N-NBOMe
gptkb:25TFM-NBOMe
|
|
gptkbp:detects
|
forensic toxicology cases
|
|
gptkbp:developedBy
|
gptkb:Ralf_Heim
|
|
gptkbp:distributionForm
|
gptkb:water
powder
blotter paper
|
|
gptkbp:firstSynthesized
|
2003
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NBOMe family
|
|
gptkbp:legalStatus
|
controlled substance in many countries
|
|
gptkbp:marketedAs
|
research chemical
|
|
gptkbp:notableMember
|
gptkb:25B-NBOMe
gptkb:25C-NBOMe
gptkb:25I-NBOMe
|
|
gptkbp:overdoseSymptoms
|
high
|
|
gptkbp:popularFor
|
increased in 2010s
|
|
gptkbp:relatedTo
|
gptkb:2C_family
|
|
gptkbp:routeOfAdministration
|
insufflation
sublingual
buccal
|
|
gptkbp:sideEffect
|
hypertension
seizures
tachycardia
hallucinations
death (in overdose)
vasoconstriction
|
|
gptkbp:structureModification
|
N-benzyl substitution
|
|
gptkbp:toxicity
|
potentially fatal
|
|
gptkbp:usedFor
|
recreational drug
|
|
gptkbp:bfsParent
|
gptkb:2C_family
|
|
gptkbp:bfsLayer
|
7
|